The Worldwide Human Identification Market is Projected to reach USD 3.1 Billion by 2030, at a CAGR of 10.6%

31-Aug-2023 | Report Format: Electronic (PDF)

Human Identification Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Human Identification Market size is expected to reach $3.1 billion by 2030, rising at a market growth of 10.6% CAGR during the forecast period.

The Forensic Laboratories segment is leading the Global Human Identification Market by End User in 2022; thereby, achieving a market value of $2.1 billion by 2030. Human identification technologies in forensic laboratories play a pivotal role in solving crimes, providing evidence for legal proceedings, and ensuring justice is served. These technologies continue to evolve and improve, aiding law enforcement agencies and legal systems in their investigative efforts.

The Instruments segment is showcasing a CAGR of 10.9% during (2023 - 2030). The utilization of identification instruments in criminal investigations and forensic science supports the expansion of the market. DNA profiling, fingerprint analysis, and facial recognition are crucial to identifying missing persons and solving crimes. Identification instruments are used more frequently due to government regulations mandating stricter identity verification at borders, airports, and other crucial infrastructure facilities.

The Forensic Applications segment acquired the highest revenue share in the Global Human Identification Market by Application in 2022; thereby achieving a market value of $1.5 billion by 2030. Human identification is utilized extensively in paternity testing, forensics, disaster victim identification, and anthropology, with DNA analysis/profiling as an essential tool in this sector. The rising global crime rate is one of the leading factors propelling the expansion of this market segment.

The Next-Generation Sequencing segment is experiencing a CAGR of 12.2% during (2023 - 2030). The order of the nucleotides in the entire genome can be determined using next-generation sequencing. This massively parallel sequencing method offers scalability, ultra-high throughput, and fast speed. Genome mapping programs, next-generation sequencing applications, healthcare spending, and technological improvements in sequencing platforms all contribute to the segment's growth.

The North America region dominated the Global Human Identification Market by Region in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1.1 billion by 2030. The Europe region is poised to grow at a CAGR of 10.4% during (2023 - 2030). Additionally, The Asia Pacific region would register a CAGR of 11.4% during (2023 - 2030).

Full Report: https://www.kbvresearch.com/human-identification-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Thermo Fisher Scientific Inc., Promega Corporation, Hamilton Company, Bio-Rad Laboratories, Inc, Qiagen N.V, SecuriGene Technologies Inc., AutoGen Inc., InnoGenomics Technologies, LLC., Carolina Biological Supply Company, and Genetek Biopharma GmbH

Global Human Identification Market Segmentation

By End User

  • Forensic Laboratories
  • Research Centers, Academic & Government Institutes

By Product

  • Assay Kits and Reagents
  • Instruments
  • Others

By Application

  • Forensic Applications
  • Paternity Identification
  • Others

By Technology

  • Polymerase Chain Reaction
  • Next-Generation Sequencing
  • Capillary Electrophoresis
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Thermo Fisher Scientific Inc.
  • Promega Corporation
  • Hamilton Company
  • Bio-Rad Laboratories, Inc
  • Qiagen N.V
  • SecuriGene Technologies Inc.
  • AutoGen Inc.
  • InnoGenomics Technologies, LLC.
  • Carolina Biological Supply Company
  • Genetek Biopharma GmbH

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale